The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Necrosulfonamide ID: ALA5197144
PubChem CID: 168285590
Max Phase: Preclinical
Molecular Formula: C18H15N5O4S2
Molecular Weight: 429.48
Associated Items:
Names and Identifiers Canonical SMILES: COc1nccnc1NSc1ccc(NC(=O)/C=C/c2ccc([N+](=O)[O-])s2)cc1
Standard InChI: InChI=1S/C18H15N5O4S2/c1-27-18-17(19-10-11-20-18)22-29-14-4-2-12(3-5-14)21-15(24)8-6-13-7-9-16(28-13)23(25)26/h2-11H,1H3,(H,19,22)(H,21,24)/b8-6+
Standard InChI Key: FGPCZTDKAJLINE-SOFGYWHQSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-3.7701 1.0914 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.1025 0.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3575 -0.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1826 -0.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4375 0.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2346 0.8201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.8181 0.2366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.4482 1.6171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3055 0.8201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7220 0.2366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9249 0.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3414 -0.1333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4556 0.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6694 0.8773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4644 1.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0480 0.5058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8370 -0.2877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0417 -0.5057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8451 0.7194 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.4286 0.1359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2257 0.3494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4395 1.1465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2345 1.3587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8181 0.7750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6071 -0.0184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8118 -0.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5982 -1.0336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1817 -1.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7113 1.2472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 2 0
1 5 1 0
6 5 1 0
6 7 2 0
6 8 1 0
2 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
14 13 2 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
13 18 1 0
16 19 1 0
19 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
26 27 1 0
27 28 1 0
11 29 2 0
M CHG 2 6 1 8 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 429.48Molecular Weight (Monoisotopic): 429.0565AlogP: 4.23#Rotatable Bonds: 8Polar Surface Area: 119.28Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.56CX Basic pKa: 0.45CX LogP: 4.20CX LogD: 4.20Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.24Np Likeness Score: -1.79
References 1. Cui B, Yan B, Wang K, Li L, Chen S, Zhang Z.. (2022) Discovery of a New Class of Uracil Derivatives as Potential Mixed Lineage Kinase Domain-like Protein (MLKL) Inhibitors., 65 (19.0): [PMID:36136378 ] [10.1021/acs.jmedchem.2c00548 ]